For example, vitexin‐mediated activation of the Vitamin D receptor (VDR) has been shown to mitigate inflammation‐driven CRC progression, emphasizing the role of tumor microenvironment interactions in CRC development [19]. The gene discussed is VDR; the disease is neoplasm.